1phar2-2002.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) PHARMANETICS, INC. ----------------------------------------------------------------------- (Name of Issuer) COMMON STOCK ----------------------------------------------------------------------- (Title of Class of Securities) 71713J107 ----------------------------------------------------------------------- (CUSIP Number) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 71713J107 13G Page 2 of 5 ======================================================================= 1. Name of Reporting Persons/I.R.S. Identification Nos. of Above persons (Entities Only) Davenport & Company LLC 54-1835842 ----------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [_] (b) [x] 3. SEC Use Only ----------------------------------------------------------------------- 4. Citizenship or Place of Organization Virginia Limited Liability Company ----------------------------------------------------------------------- (5) SOLE VOTING POWER NUMBER OF 0 SHARES ---------------------------------------------------- (6) SHARED VOTING POWER BENEFICIALLY 0 OWNED BY ---------------------------------------------------- EACH (7) SOLE DISPOSITIVE POWER REPORTING 313,756 PERSON ---------------------------------------------------- (8) SHARED DISPOSITIVE POWER WITH 0 ---------------------------------------------------------------------- 9) Aggregate Amount Beneficially Owned by Each Reporting Person 313,756 10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ----------------------------------------------------------------------- CUSIP NO. 71713J107 13G Page 3 of 5 11) Percent of Class Represented by Amount in Row (9) 3.26% ----------------------------------------------------------------------- 12) Type Of Reporting Person (See Instructions) BD,IA ======================================================================= Item 1 (a) Name of Issuer: PHARMANETICS, INC. (b) Address of Issuer's Principal Executive Offices: 9401 Globe Center Drive, Suite 140 Morrisville, NC 28560 Item 2 (a) Name of Person Filing: Davenport & Company LLC (b) Address of Principal Business Office or, if none, Residence: 901 E. Cary St., Suite 1100 Richmond, VA 23219 (c) Citizenship: VA LLC (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 7173J107 Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: (a) [x] Broker or dealer registered under section 15 of the Exchange Act; (b) [_] Bank as defined in section 3(a)(6) of the Exchange Act; (c) [_] Insurance company as defined in section 3(a)(19) of the Exchange Act; (d) [_] Investment company registered under section 8 of the Investment Company Act; (e) [x] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act; CUSIP NO. 71713J107 13G Page 4 of 5 ======================================================================= (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the investment company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [] Item 4. Ownership: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 313,756 (b) Percent of class: 3.26% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 313,756 (iv) shared power to dispose or to direct the disposition of: 0 THE 313,756 SHARES REPORTED AS BEING HELD WITH SOLE DISPOSITIVE POWER ARE HELD BY 102 CUSTOMER ACCOUNTS OF DAVENPORT & COMPANY LLC THAT HAVE GIVEN CERTAIN DISCRETIONARY AUTHORIZATIONS TO CERTAIN REGISTERED REPRESENTATIVES OF DAVENPORT WITH RESPECT TO THE MANAGEMENT OF THE INVESTMENT ACCOUNTS IN THE ORDINARY COURSE OF BUSINESS. NO ONE INDIVIDUAL OR ACCOUNT HOLDS 5% OR MORE OF THE OUTSTANDING VOTING SECURITIES OF THE ISSUER IN QUESTION AND NO ONE IS ACTING IN CONCERT WITH RESPECT TO SUCH INVESTMENTS AND EACH HAS SPECIFICALLY DISCLAIMED BOTH BENEFICIAL OWNERSHIP IN ANY OF SUCH OTHER INDIVIDUAL'S SECURITIES AND THE EXISTENCE OF A GROUP. DAVENPORT ALSO HAS SPECIFICALLY DISCLAIMED BOTH BENEFICIAL OWNERSHIP IN ANY OF SUCH INDIVIDUAL'S SECURITIES AND THE EXISTENCE OF A GROUP. Item 5. Ownership of Five Percent or Less of a Class: [x] Item 6. Ownership of More than Five Percent on Behalf of Another Person: CUSIP NO. 71713J107 13G Page 5 of 5 Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: Not applicable Item 8. Identification and Classification of Members of the Group: Not applicable Item 9. Notice of Dissolution of a Group: Not applicable Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 2, 2003 /s/ J. Lee Keiger, III -------------------- J. Lee Keiger, III